Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation.
Anomalies in the regulation and function of integrins have been implicated in the etiology of various pathologic conditions, including inflammatory disorders such as irritable bowel disease. Several classes of cell surface glycoproteins such as CD98 have been shown to play roles in integrins-mediated events. Here, we investigated the role of CD98 in intestinal inflammation using both in vivo and in vitro approaches. We found that in Caco2-BBE monolayers and colonic tissues, expression of CD98 was upregulated by the proinflammatory cytokine, interferon gamma (INF gamma). Furthermore, CD98 was highly upregulated in colonic tissues from mice with active colitis induced by dextran sodium sulfate (DSS), but not in DSS-treated INF gamma -/- mice. Administration of an anti-CD98 antibody worsened DSS-induced colitis in mice but had no effect on untreated control mice. Finally, we used Caco2-BBE cell monolayers to model intestinal epithelial wound healing, and found that activation of epithelial CD98 in DSS-treated monolayers inhibited monolayer reconstitution, but had no affect on untreated control monolayers. Our data collectively indicate that (i) CD98 upregulation is mediated by INF gamma during intestinal inflammation and (ii) activation of epithelial CD98 protein aggravates intestinal inflammation by reducing intestinal epithelial reconstitution. Overall, our data suggest that epithelial CD98 plays an important role in the perpetuation of intestinal inflammation.
Kucharzik
Torsten
T
Department of Medicine B, Münster University of Münster, Germany.
Lugering
Andreas
A
Yan
Yutao
Y
Driss
Adel
A
Charrier
Laetitia
L
Sitaraman
Shanthi
S
Merlin
Didier
D
D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D018938:Caco-2 Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D002448:Cell Adhesion / Q000187:drug effects; D003092:Colitis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D003106:Colon / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D016264:Dextran Sulfate / Q000494:pharmacology; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D027261:Fusion Regulatory Protein-1 / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D006801:Humans; D007274:Injections, Intraperitoneal; D007371:Interferon-gamma / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D011994:Recombinant Proteins; D015854:Up-Regulation; D014945:Wound Healing / Q000187:drug effects
D019138:Antibodies, Blocking; D027261:Fusion Regulatory Protein-1; D011994:Recombinant Proteins; D007371:Interferon-gamma; D016264:Dextran Sulfate